CHILDREN'S ZYRTEC HIVES

LOE Approaching

cetirizine hydrochloride

NDAORALSOLUTION
Approved
Nov 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Indications (4)

these symptoms due to hay feverother upper respiratory allergies: runny nose sneezing itchywatery eyes itching of the nosethroat

Clinical Trials (3)

NCT04189588Phase 2Completed

Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine

Started Mar 2020
34 enrolled
Oncology Patients Receiving Chemotherapy
NCT00881127Phase 1Completed

To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions

Started Jul 2005
40 enrolled
Allergies
NCT00881634Phase 1Completed

To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions

Started Jun 2005
40 enrolled
Allergies
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers